Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Porter

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Molecular Therapy. Oncology|June 23, 2025
Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinomaGreyson Biegert, Amanda Rosewell Shaw, Daisuke Morita, et al.
Maternal Health, Neonatology and Perinatology|December 23, 2017
NEC-zero recommendations from scoping review of evidence to prevent and foster timely recognition of necrotizing enterocolitisSheila M Gephart, Corrine Hanson, Christine M Wetzel, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Molecular Therapy. Oncology|June 23, 2025
Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinomaGreyson Biegert, Amanda Rosewell Shaw, Daisuke Morita, et al.
Maternal Health, Neonatology and Perinatology|December 23, 2017
NEC-zero recommendations from scoping review of evidence to prevent and foster timely recognition of necrotizing enterocolitisSheila M Gephart, Corrine Hanson, Christine M Wetzel, et al.
Pageof 2